Cite
HARVARD Citation
Linch, S. et al. (2015). Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Linch, S. et al. (2015). Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online].